Nu Skin Enterprises director sells $24,640 in stock
NUS
-0.60%
Add to/Remove from Watchlist
Add to Watchlist
Add Position
Position added successfully to:
Please name your holdings portfolio
Type:
BUY
SELL
Date:
Amount:
Price
Point Value:
Leverage:
1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000
Commission:
Create New Watchlist
Create
Create a new holdings portfolio
Add
Create
+ Add another position
Close
In a recent transaction on March 25, Andrew D. Lipman, a board director of Nu Skin Enterprises, Inc. (NYSE:NUS), sold 2,000 shares of the company’s stock. The sale was executed at a price of $12.32 per share, totaling $24,640.
This transaction was carried out in accordance with a prearranged trading plan that complies with the guidelines of Rule 10b5-1, which allows company insiders to set up a trading plan for selling stocks they own. Following this sale, Lipman’s direct holdings in Nu Skin Enterprises stand at 27,225 shares.
The sale took place amidst the market’s ongoing assessment of insider transactions, which are closely monitored as they can provide insights into a company’s prospects. Nu Skin Enterprises, known for its personal care products and dietary supplements, has a presence in the wholesale proprietary drugs and druggists’ sundries sector.
Investors and stakeholders of Nu Skin Enterprises keep an eye on such transactions to better understand the actions of the company’s insiders and to gauge the stock’s potential future direction. The details of the sale are now publicly available following the required regulatory filing.
InvestingPro Insights
Amidst the recent insider transaction by board director Andrew D. Lipman, Nu Skin Enterprises (NYSE:NUS) has shown several financial metrics that may be of interest to investors. With a market capitalization of $619.74 million and a high gross profit margin of 72.26% over the last twelve months as of Q4 2023, the company demonstrates a strong ability to retain earnings after the cost of goods sold.
One of the InvestingPro Tips for Nu Skin is the company’s impressive gross profit margins, which align with the reported gross profit of $1422.98 million. This financial health indicator is crucial for stakeholders to consider, particularly when analyzing the company’s operational efficiency and potential for profitability.
Another notable InvestingPro Tip is that Nu Skin has raised its dividend for 23 consecutive years, despite a recent decline in dividend growth of -84.42%. This consistent history of dividend payments may appeal to income-focused investors, especially considering the current dividend yield of 1.92%.
However, the company’s stock has been under pressure, trading near its 52-week low and having experienced a significant price drop over the last year, with a one-year price total return of -66.06%. This may indicate a potential opportunity for investors to buy shares at a lower price point, which is further supported by the InvestingPro fair value estimation of $18.13, above the previous close price of $12.30.
For those seeking additional insights, there are many more InvestingPro Tips available on the platform, including expectations for net income growth this year and the stock’s performance over various periods. To access these tips and more detailed analytics, visit https://www.investing.com/pro/NUS and use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
